| Report ID |
113317 |
| Drug Identification Number |
02241114 |
| Brand name |
AVANDIA |
| Common or Proper name |
rosiglitazone (as rosiglitazone maleate) tablets |
| Company Name |
GLAXOSMITHKLINE INC |
| Market Status |
CANCELLED POST MARKET |
| Active Ingredient(s) |
ROSIGLITAZONE |
| Strength(s) |
8MG |
| Dosage form(s) |
TABLET |
| Route of administration |
ORAL
ORAL |
| Packaging size |
60's |
| ATC code |
A10BG |
| ATC description |
BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for discontinuation |
Business reasons |
| Anticipated discontinuation date |
|
| Actual discontinuation date |
2020-04-22 |
| Remaining supply date |
2019-09-30 |
| Discontinuation status |
Discontinued |
| Discontinuation decision reversal |
No |
| Information on remaining supply |
|
| Company comments |
|
| Health Canada comments |
|
| Company contact information |
1-800-387-7374 |
